Sam Altman says Trump could be a ‘visionary leader’ in supporting AI infrastructure
https://www.marketwatch.com/bulletins/redirect/go?g=c3f77740-db75-471f-b7e5-921f002f530f&mod=mw_rss_bulletins
HUTCHMED to receive milestone payment as Takeda launches FRUZAQLA for colorectal cancer treatment in Japan
(RTTNews) – HUTCHMED (China) Limited (HCM) announced that it will receive a milestone payment following the price approval and launch of FRUZAQLA (fruquintinib) 1 mg/5 mg capsules in Japan by…
Read more